BMY

Bristol-Myers Squibb Company

Healthcare

59.75 -0.82 -1.35% Pre-Market

2026-10-16 • USD

Key Metrics

Market Cap 122.05B

EV 159.15B

Shares Out 2.04B

Revenue (ttm) 49.19B

Net Income 9.28B

Beta —

P/E —

Forward P/E —

EPS (ttm) $4.55

P/S 2.48

P/B 5.47

P/FCF 10.67

P/C 9.55

EV/Sales 3.24

EV/EBITDA 44.62

ROA 10.06%

ROE 45.42%

ROIC —

Gross Margin —

Oper. Margin —

Profit Margin 18.87%

Debt/Eq 2.05

LT Debt/Cap 65.35%

Quick Ratio 0.95

Current Ratio 1.53

Book/sh 10.93

Cash/sh 4.27

Div Yield 4.2%

Div TTM $2.51

Payout Ratio 55.16%

SMA20 -1.47%

SMA50 -5.91%

SMA200 0.19%

Volume 12,823,530

Avg Volume 11.90M

Rel Volume 1.08

Perf Week 3.77%

Perf Month -5.25%

Perf Quarter -1.63%

Perf Half Y -0.70%

Perf YTD 10.77%

Perf Year 36.95%

Perf 3Y 5.79%

Perf 5Y 3.75%

Factor Lens

Seasonal Performance

Dividends

Per-share amounts adjusted for stock splits.

Last Dividend $0.6300

TTM Yield 4.20%

TTM Amount $2.51

Payout Ratio 55.16%

3-Yr Growth (CAGR) 4.37%

5-Yr Growth (CAGR) 6.24%

Last 12 Payouts

Period	Ex-Date	Amount / Share
Q2 2026	~2026-06-30	$0.6300
Q1 2026	~2026-03-31	$0.6300
Q4 2025	~2025-12-30	$0.6300
Q3 2025	~2025-09-30	$0.6200
Q2 2025	~2025-06-30	$0.6200
Q1 2025	~2025-03-31	$0.6200
Q4 2024	~2024-12-30	$0.6200
Q3 2024	~2024-09-30	$0.6000
Q2 2024	~2024-06-30	$0.6000
Q1 2024	~2024-03-31	$0.6000
Q4 2023	~2023-12-30	$0.6000
Q3 2023	~2023-09-30	$0.5700

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

Bristol-Myers Squibb Company is a global biopharmaceutical company dedicated to transforming patients' lives through science. The company discovers, develops and delivers…

Name: Bristol-Myers Squibb Company
Sector: Healthcare
Industry: Drug Manufacturers - General
CEO: Christopher S. Boerner · Board Chair and Chief Executive Officer
Employees: —
IPO Date: 2019-03-12
Phone: (609) 252-4621
Address: Route 206 & Province Line Road, Princeton, NJ 08543
Website: —

Key Executives

Name	Title	FY Pay
Julia A. Haller	Director	—
Deepak L. Bhatt	Director	—
Peter J. Arduini	Director	—
Theodore R. Samuels	Lead Independent Director	—
Christopher S. Boerner	Board Chair and Chief Executive Officer	—

Latest News

2026-04-26
Bristol Myers Squibb: Low Volatility Meets High Dividend Yield fool.com
2026-04-26
Advisors Capital Management LLC Raises Stake in Bristol Myers Squibb Company $BMY defenseworld.net
2026-04-25
3 Healthcare Stocks That Pay You a Dividend While You Wait for a Recovery fool.com
2026-04-24
Should You Buy, Hold, or Sell BMY Stock Ahead of Q1 Earnings? zacks.com
2026-04-24
Bristol Myers, Pfizer to offer blockbuster blood thinner through Mark Cuban's online pharmacy reuters.com
2026-04-24
Bristol Myers Squibb and Pfizer to Make Eliquis® (apixaban) Available via Mark Cuban Cost Plus Drug Company businesswire.com
2026-04-24
Bristol Myers Squibb Company $BMY Holdings Raised by Caprock Group LLC defenseworld.net
2026-04-24
Bristol Myers Squibb: Strong Pipeline, Weak Outlook (Rating Downgrade) seekingalpha.com

BMY